Simulations Plus, Inc. (NASDAQ:SLP) Shares Sold by Squarepoint Ops LLC

Squarepoint Ops LLC reduced its position in shares of Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 52.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 11,625 shares of the technology company's stock after selling 12,972 shares during the period. Squarepoint Ops LLC owned 0.06% of Simulations Plus worth $324,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the company. Janus Henderson Group PLC boosted its stake in Simulations Plus by 7,753.3% in the 4th quarter. Janus Henderson Group PLC now owns 542,899 shares of the technology company's stock worth $15,141,000 after buying an additional 535,986 shares during the last quarter. Royce & Associates LP boosted its position in shares of Simulations Plus by 56.6% in the fourth quarter. Royce & Associates LP now owns 371,797 shares of the technology company's stock worth $10,369,000 after acquiring an additional 134,381 shares during the last quarter. Nicholas Company Inc. acquired a new stake in shares of Simulations Plus in the fourth quarter worth approximately $3,418,000. Kennedy Capital Management LLC boosted its holdings in shares of Simulations Plus by 59.4% in the 4th quarter. Kennedy Capital Management LLC now owns 289,286 shares of the technology company's stock valued at $8,068,000 after purchasing an additional 107,766 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in shares of Simulations Plus by 210.7% in the 4th quarter. JPMorgan Chase & Co. now owns 147,154 shares of the technology company's stock valued at $4,104,000 after purchasing an additional 99,789 shares during the last quarter. 78.08% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Simulations Plus

In related news, Director Walter S. Woltosz sold 20,000 shares of the business's stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $33.51, for a total value of $670,200.00. Following the transaction, the director now owns 3,344,157 shares in the company, valued at approximately $112,062,701.07. The trade was a 0.59% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 19.40% of the company's stock.

Wall Street Analyst Weigh In

SLP has been the topic of a number of research analyst reports. William Blair reiterated an "outperform" rating on shares of Simulations Plus in a report on Tuesday. KeyCorp lifted their target price on Simulations Plus from $32.00 to $40.00 and gave the company an "overweight" rating in a report on Wednesday, April 16th. Finally, Wall Street Zen raised Simulations Plus from a "sell" rating to a "hold" rating in a research note on Monday, April 28th. Two analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $50.00.

Simulations Plus Trading Down 0.9%

NASDAQ:SLP opened at $27.55 on Friday. The firm's fifty day simple moving average is $30.63 and its 200 day simple moving average is $30.37. The firm has a market capitalization of $554.06 million, a price-to-earnings ratio of 68.88 and a beta of 0.97. Simulations Plus, Inc. has a twelve month low of $23.01 and a twelve month high of $50.11.

Simulations Plus (NASDAQ:SLP - Get Free Report) last issued its quarterly earnings data on Thursday, April 3rd. The technology company reported $0.31 EPS for the quarter, topping analysts' consensus estimates of $0.25 by $0.06. The company had revenue of $22.43 million for the quarter, compared to analysts' expectations of $21.93 million. Simulations Plus had a return on equity of 6.84% and a net margin of 10.97%. The firm's quarterly revenue was up 22.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.20 earnings per share. On average, analysts predict that Simulations Plus, Inc. will post 1.09 earnings per share for the current year.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.